GeneCellNano Flagship develops new biological drugs, so-called ATMP products, biomarkers and diagnostics for diseases with unmet clinical need. New treatments are developed for cardiovascular diseases and age-related macular degeneration, as well as for brain, ovarian and bladder cancer.

Project information

Project duration


Project coordinator

Other university or unit

Contact information

Project leader

Contact person

Project description

From the University of Oulu, our investigators are professors Seppo Vainio, Peppi Karppinen, and Lauri Eklund.

Please visit the GeneCellNano website at